HC Wainwright & Co. Reiterates Buy on Replimune Group, Maintains $17 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating for Replimune Group, maintaining a price target of $17. Analyst Robert Burns continues to support the stock, indicating confidence in its potential.
September 10, 2024 | 10:58 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating for Replimune Group, maintaining a price target of $17. Analyst Robert Burns continues to support the stock, indicating confidence in its potential.
The reiteration of a Buy rating and maintenance of a $17 price target by a reputable analyst can positively influence investor sentiment and potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100